US Patent Litigations are now available. Check here

Explore Neurim Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3103443Jun 30, 2021Method For Treating Primary Insomnia6
EP1441702May 10, 2017Method For Treating Primary Insomnia4